A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.3256-3257
Main Authors: Guest, Erin, Kairalla, John, Devidas, Meenakshi, Hibbitts, Emily, Carroll, Andrew J., Heerema, Nyla A., Kubaney, Holly, August, Amanda, Pauly, Melinda, Wechsler, Daniel, Miles, Rodney R., Reid, Joel M., Kihei, Cynthia, Gore, Lia, Raetz, Elizabeth A., Hunger, Stephen P., Loh, Mignon L., Brown, Patrick A.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-167765